384 related articles for article (PubMed ID: 26195820)
1. RIP1 Cleavage in the Kinase Domain Regulates TRAIL-Induced NF-κB Activation and Lymphoma Survival.
Zhang L; Blackwell K; Workman LM; Chen S; Pope MR; Janz S; Habelhah H
Mol Cell Biol; 2015 Oct; 35(19):3324-38. PubMed ID: 26195820
[TBL] [Abstract][Full Text] [Related]
2. TRAIL activates JNK and NF-κB through RIP1-dependent and -independent pathways.
Zhang L; Dittmer MR; Blackwell K; Workman LM; Hostager B; Habelhah H
Cell Signal; 2015 Feb; 27(2):306-14. PubMed ID: 25446254
[TBL] [Abstract][Full Text] [Related]
3. The C-terminal domain of the long form of cellular FLICE-inhibitory protein (c-FLIPL) inhibits the interaction of the caspase 8 prodomain with the receptor-interacting protein 1 (RIP1) death domain and regulates caspase 8-dependent nuclear factor κB (NF-κB) activation.
Matsuda I; Matsuo K; Matsushita Y; Haruna Y; Niwa M; Kataoka T
J Biol Chem; 2014 Feb; 289(7):3876-87. PubMed ID: 24398693
[TBL] [Abstract][Full Text] [Related]
4. The involvement of β-actin in the signaling of transmembrane TNF-α-mediated cytotoxicity.
Chen H; Xiao L; Zhang H; Liu N; Liu T; Liu L; Hu X; Yan D; Yang K; Yin B; Wang J; Li Q; Li Z
J Leukoc Biol; 2011 Jun; 89(6):917-26. PubMed ID: 21402772
[TBL] [Abstract][Full Text] [Related]
5. RIP1 is required for IAP inhibitor-mediated sensitization for TRAIL-induced apoptosis via a RIP1/FADD/caspase-8 cell death complex.
Abhari BA; Cristofanon S; Kappler R; von Schweinitz D; Humphreys R; Fulda S
Oncogene; 2013 Jul; 32(27):3263-73. PubMed ID: 22890322
[TBL] [Abstract][Full Text] [Related]
6. MAPK p38 and JNK have opposing activities on TRAIL-induced apoptosis activation in NSCLC H460 cells that involves RIP1 and caspase-8 and is mediated by Mcl-1.
Azijli K; Yuvaraj S; van Roosmalen I; Flach K; Giovannetti E; Peters GJ; de Jong S; Kruyt FA
Apoptosis; 2013 Jul; 18(7):851-60. PubMed ID: 23456625
[TBL] [Abstract][Full Text] [Related]
7. Distinct Activation Mechanisms of NF-κB Regulator Inhibitor of NF-κB Kinase (IKK) by Isoforms of the Cell Death Regulator Cellular FLICE-like Inhibitory Protein (cFLIP).
Baratchian M; Davis CA; Shimizu A; Escors D; Bagnéris C; Barrett T; Collins MK
J Biol Chem; 2016 Apr; 291(14):7608-20. PubMed ID: 26865630
[TBL] [Abstract][Full Text] [Related]
8. Kurarinone promotes TRAIL-induced apoptosis by inhibiting NF-κB-dependent cFLIP expression in HeLa cells.
Seo OW; Kim JH; Lee KS; Lee KS; Kim JH; Won MH; Ha KS; Kwon YG; Kim YM
Exp Mol Med; 2012 Nov; 44(11):653-64. PubMed ID: 22932446
[TBL] [Abstract][Full Text] [Related]
9. NF-kappaB inhibition reveals differential mechanisms of TNF versus TRAIL-induced apoptosis upstream or at the level of caspase-8 activation independent of cIAP2.
Diessenbacher P; Hupe M; Sprick MR; Kerstan A; Geserick P; Haas TL; Wachter T; Neumann M; Walczak H; Silke J; Leverkus M
J Invest Dermatol; 2008 May; 128(5):1134-47. PubMed ID: 17989734
[TBL] [Abstract][Full Text] [Related]
10. NF-kappaB inducers upregulate cFLIP, a cycloheximide-sensitive inhibitor of death receptor signaling.
Kreuz S; Siegmund D; Scheurich P; Wajant H
Mol Cell Biol; 2001 Jun; 21(12):3964-73. PubMed ID: 11359904
[TBL] [Abstract][Full Text] [Related]
11. IRF-1 inhibits NF-κB activity, suppresses TRAF2 and cIAP1 and induces breast cancer cell specific growth inhibition.
Armstrong MJ; Stang MT; Liu Y; Yan J; Pizzoferrato E; Yim JH
Cancer Biol Ther; 2015; 16(7):1029-41. PubMed ID: 26011589
[TBL] [Abstract][Full Text] [Related]
12. Constitutively active Akt1 protects HL60 leukemia cells from TRAIL-induced apoptosis through a mechanism involving NF-kappaB activation and cFLIP(L) up-regulation.
Bortul R; Tazzari PL; Cappellini A; Tabellini G; Billi AM; Bareggi R; Manzoli L; Cocco L; Martelli AM
Leukemia; 2003 Feb; 17(2):379-89. PubMed ID: 12592338
[TBL] [Abstract][Full Text] [Related]
13. Cellular FLICE-inhibitory protein (cFLIP) isoforms block CD95- and TRAIL death receptor-induced gene induction irrespective of processing of caspase-8 or cFLIP in the death-inducing signaling complex.
Kavuri SM; Geserick P; Berg D; Dimitrova DP; Feoktistova M; Siegmund D; Gollnick H; Neumann M; Wajant H; Leverkus M
J Biol Chem; 2011 May; 286(19):16631-46. PubMed ID: 21454681
[TBL] [Abstract][Full Text] [Related]
14. FADD regulates NF-κB activation and promotes ubiquitination of cFLIPL to induce apoptosis.
Ranjan K; Pathak C
Sci Rep; 2016 Mar; 6():22787. PubMed ID: 26972597
[TBL] [Abstract][Full Text] [Related]
15. Smac mimetic sensitizes glioblastoma cells to Temozolomide-induced apoptosis in a RIP1- and NF-κB-dependent manner.
Wagner L; Marschall V; Karl S; Cristofanon S; Zobel K; Deshayes K; Vucic D; Debatin KM; Fulda S
Oncogene; 2013 Feb; 32(8):988-97. PubMed ID: 22469979
[TBL] [Abstract][Full Text] [Related]
16. TWEAK induces apoptosis through a death-signaling complex comprising receptor-interacting protein 1 (RIP1), Fas-associated death domain (FADD), and caspase-8.
Ikner A; Ashkenazi A
J Biol Chem; 2011 Jun; 286(24):21546-54. PubMed ID: 21525013
[TBL] [Abstract][Full Text] [Related]
17. RIP1 has a role in CD40-mediated apoptosis in human follicular lymphoma cells.
Adem J; Eray M; Eeva J; Nuutinen U; Pelkonen J
Immunobiology; 2017 Nov; 222(11):998-1003. PubMed ID: 28610909
[TBL] [Abstract][Full Text] [Related]
18. TNF Apoptosis Protection Fraction (TAPF) prevents apoptosis induced by TNF, but not by Fas or TRAIL, via NF-κB-induced increase in cFLIP.
Seol JY; Mihich E; Berleth ES
Cytokine; 2015 Oct; 75(2):321-9. PubMed ID: 26198031
[TBL] [Abstract][Full Text] [Related]
19. S-nitrosylation of FLICE inhibitory protein determines its interaction with RIP1 and activation of NF-κB.
Talbott SJ; Luanpitpong S; Stehlik C; Azad N; Iyer AK; Wang L; Rojanasakul Y
Cell Cycle; 2014; 13(12):1948-57. PubMed ID: 24762656
[TBL] [Abstract][Full Text] [Related]
20. cFLIPL inhibits tumor necrosis factor-related apoptosis-inducing ligand-mediated NF-kappaB activation at the death-inducing signaling complex in human keratinocytes.
Wachter T; Sprick M; Hausmann D; Kerstan A; McPherson K; Stassi G; Bröcker EB; Walczak H; Leverkus M
J Biol Chem; 2004 Dec; 279(51):52824-34. PubMed ID: 15459191
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
